Form 8-K - Current report:
SEC Accession No. 0001104659-24-058036
Filing Date
2024-05-07
Accepted
2024-05-07 16:29:02
Documents
15
Period of Report
2024-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2413671d1_8k.htm   iXBRL 8-K 27888
2 EXHIBIT 99.1 tm2413671d1_ex99-1.htm EX-99.1 65456
6 GRAPHIC tm2413671d1_ex99-1img001.jpg GRAPHIC 16788
  Complete submission text file 0001104659-24-058036.txt   301118

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20240507.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20240507_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20240507_pre.xml EX-101.PRE 22373
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2413671d1_8k_htm.xml XML 3685
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 24922435
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)